The end of a myth: Cloning and characterization of the ovine melatonin MT 2receptor

British Journal of Pharmacology

Volumn 158, Issue 5, 2009, Pages 1248-1262

  Coge F ^a   Guenin, S P ^a   Fery, I ^a   Migaud, M ^b   Devavry, S ^a,b   Slugocki, C ^b   Legros, C ^b   Ouvry, C ^a   Cohen, W ^a   Renault, N ^c   Nosjean, O ^a   Malpaux, B ^b   Delagrange, P ^a   Boutin, J A ^a,d  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^c UNIV LILLE   (France)

^d INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Cloning; Melatonin; Mt 2 receptor; Pharmacology; Sheep

Indexed keywords

4 PHENYL 2 PROPIONAMIDOTETRALIN; LUZINDOLE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MESSENGER RNA; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CHOROID PLEXUS; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HYPOTHALAMUS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SHEEP;

AMINO ACID SEQUENCE; ANIMALS; BRAIN; CATTLE; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; CRICETULUS; FEMALE; GTP-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; RADIOLIGAND ASSAY; RATS; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; RECOMBINANT PROTEINS; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SHEEP; TETRAHYDRONAPHTHALENES; TRYPTAMINES;

EID: 70849094945     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00453.x     Document Type: Article

References (57)

1. Alarma-Estrany P, Pintor J (2007). Melatonin receptors in the eye: location, second messengers and role in ocular physiology. Pharmacol Ther 113: 507-522. (Pubitemid 46365956)
2. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition (2008 revision). Br J Pharmacol 153: S1-S209.
3. Arendt J (2005). Melatonin: characteristics, concerns, and prospects. J Biol Rhythms 20: 291-303.
4. Audinot V, Mailliet F, Lahaye C, Bonnaud A, Le Gall A, Amosse A et al (2003). New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn Schmiedebergs Arch Pharmacol 367: 553-561.
5. 2 receptors. Biochem Pharmacol 75: 2007-2015.
6. Ayoub MA, Levoye A, Delagrange P, Jockers R (2004). Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol Pharmacol 66: 312-321. (Pubitemid 38989488)
7. Baldwin JM, Schertlera GFX, Ungera VM (1997). An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol 272: 144-164. (Pubitemid 27395544)
8. Ballesteros JA, Jensen AD, Liapakis G, Rasmussen SG, Shi L, Gether U etal. (2001). Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem 276: 29171-29177.
9. Barrett P, Conway S, Morgan PJ (2003). Digging deep-structure function relationships in the melatonin receptor family. J Pineal Res 35: 221-230. (Pubitemid 37338854)
10. Boutin JA, Audinot V, Ferry G, Delagrange P (2005). Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sei 26: 412-419. (Pubitemid 41039217)
11. Browning C, Beresford I, Fraser N, Giles H (2000). Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors. Br J Pharmacol 129: 877-886. (Pubitemid 30142898)
12. Brunner P, Sözer-Topcular N, Jockers R, Ravid R, Angeloni D, Fraschini F et al. (2006). Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. Eur J Histochem 50: 311-316.
13. Cheng YC, Prussoff WH (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
14. Conway S, Canning SJ, Barrett P, Guardiola-Lemaitre B, Delagrange P, Morgan PJ (1997). The roles of valine 208 and histidine 211 in ligand binding and receptor function of the ovine Mella beta melatonin receptor. Biochem Biophys Res Commun 239: 418-423. (Pubitemid 27488978)
15. Conway S, Drew JE, Mowat ES, Barrett P, Delagrange P, Morgan PJ (2000). Chimeric melatonin mt1 and melatonin-related receptors. Identification of domains and residues participating in ligand binding and receptor activation of the melatonin mtl receptor. J. Biol Chem 275: 20602-20609. (Pubitemid 30457645)
16. Drew JE, Barrett P, Williams LM, Conway S, Morgan PJ (1998). The ovine melatonin-related receptor: cloning and preliminary distribution and binding studies. J Neuroendocrinal 10: 651-661. (Pubitemid 28393732)
17. Drew JE, Barrett P, Conway S, Delagrange P, Morgan PJ (2002). Differential coupling of the extreme C-terminus of G protein alpha subunits to the G protein-coupled melatonin receptors. Biochim Biophys Acta 1592: 185-192.
18. Dubocovich ML (1995). Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 16: 50-56.
19. Dubocovich ML, Markowska M (2005). Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27: 101-110.
20. Gerdin MJ, Mseeh F, Dubocovich ML (2003). Mutagenesis studies of the human MT2 melatonin receptor. Biochem Pharmacol 66: 315-320. (Pubitemid 36776405)
21. Grol CJ, Jansen JM (1996). The high affinity melatonin binding site probed with conformationally restricted ligands-II. Homology modeling of the receptor. Bioorg Med Chem 4: 1333-1339. (Pubitemid 26284242)
22. Imbesi M, Uz T, Dzitoyeva S, Giusti P, Manev H (2008). Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors. Brain Res 1227: 19-25.
23. Jin X, von Gall C, Pieschl RL, Gribkoff VK, Stehle JH, Reppert SM et al. (2003). Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 23: 1054-1060. (Pubitemid 36133521)
24. Jockers R, Maurice P, Boutin JA, Delagrange P (2008). Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J. Pharmacol 154: 1182-1195. (Pubitemid 351992057)
25. Mailliet F, Audinot V, Malpaux B, Bonnaud A, Delagrange P, Migaud M et al. (2004). Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MTl and MT2 receptors. Biochem Pharmacol 67: 667-677. (Pubitemid 38125251)
26. Malpaux B (2006). Seasonal regulation of reproduction in mammals. In: Neil JD (ed.). Knobil and Neil's Physiology of Reproduction, 3rd edition. Academic Press Inc.: Burlington, MA, pp. 2231-2281.
27. Malpaux B, Daveau A, Maurice-Mandon F, Duarte G, Chemlneau P (1998). Evidence that melatonin acts in the premammillary hypothalamic area to control reproduction in the ewe: presence of binding sites and stimulation of luteinizing hormone secretion by in situ microimplant delivery. Endocrinology 139: 1508-1516. (Pubitemid 28513803)
28. Mazna P, Berka K, Jelinkova I, Balik A, Svoboda P, Obsilova V et al. (2005). Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7. Biochem Biophys Res Commun 332: 726-734. (Pubitemid 40745174)
29. Migaud M, Daveau A, Malpaux B (2005). MTNR1A melatonin receptors in the ovine premammillary hypothalamus: day-night variation in the expression of the transcripts. Biol Reprod 72: 393-398. (Pubitemid 40129715)
30. Morgan PJ, Davidson G, Lawson W, Barrett P (1990). Both pertussis toxin-sensitive and insensitive G proteins link melatonin receptor to inhibition of adenylyl cyclase in the ovine pars tuberalis. J Neuroendocrinal 2: 773-776.
31. Mseeh F, Gerdin MJ, Dubocovich ML (2002). Identification of cysteines Involved in ligand binding to the human melatonin MT(2) receptor. Eur J Pharmacol 449: 29-38. (Pubitemid 34887987)
32. Musshoff U, Riewenherm D, Berger E, Fauteck JD, Speckmann EJ (2002). Melatonin receptors in rat hippocampus: molecular and functional investigations. Hippocampus 12: 165-173. (Pubitemid 34436701)
33. Nelson CS, Ikeda M, Gompf HS, Robinson ML, Fuchs NK, Yoshloka T et al (2001). Regulation of melatonin la receptor signaling and trafficking by asparagine-124. Mol Endocrinol 15: 1306-1317. (Pubitemid 32703479)
34. Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F et al (2000). Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 275: 31311-31317.
35. Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N et al. (2008). Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 85: 335-353.
36. Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E (2002). Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 13: 336-343.
37. Pelletier J, Bodin L, Hanocq E, Malpaux B, Teyssier J, Thimonier J et al. (2000). Association between expression of reproductive seasonality and alleles of the gene for Mel(1a) receptor in the ewe. Biol Reprod 62: 1096-1101. (Pubitemid 30173827)
38. Peters MF, Knappenberger KS, Wilkins D, Sygowski LA, Lazor LA, Liu J etal (2007). Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs. J Biomol Screen 12: 312-319.
39. Poirel VJ, Cailotto C, Streicher D, Pévet P, Masson-Pévet M, Gauer F (2003). MTl melatonin receptor mRNA tissular localization by PCR amplification. Neuro Endocrinol Lett 24: 33-38. (Pubitemid 36559497)
40. Reppert SM, Weaver DR, Eblsawa T (1994). Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13: 1177-1185.
41. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF (1995). Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Melib melatonin receptor. Proc Natl Acad Sci USA 92: 8734-8738.
42. Reppert SM, Weaver DR, Ebisawa T, Mahle CD, Kolakowski LF (1996). Cloning of a melatonin-related receptor from human pituitary. FEBS Lett 386: 219-224. (Pubitemid 26170143)
43. Roca AL, Godson C, Weaver DR, Reppert SM (1996). Structure, characterization, and expression of the gene encoding the mouse Mella melatonin receptor. Endocrinology 137: 3469-3477. (Pubitemid 26250201)
44. Roka F, Brydon L, Waldhoer M, Strosberg AD, Freissmuth M, Jockers R etal. (1999). Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity. Mol Pharmacol 56: 1014-1024.
45. Sallinen P, Saarela S, lives M, Vakkuri O, Leppäluoto J (2005). The expression of MT1 and MT2 melatonin receptor mRNA In several rat tissues. Life Sci 76: 1123-1134.
46. Savaskan E, Wirz-Justice A, Olivieri G, Pache M, Kräuchi K, Brydon L et al (2002). Distribution of melatonin MTl receptor immunoreactivity in human retina. J Histochem Cytochem 50: 519-526.
47. Savaskan E, Ayoub MA, Ravid R, Angeloni D, Fraschini F, Meier F et al (2005). Reduced hlppocampal MT2 melatonin receptor expression in Alzheimer's disease. J Pineal Res 38: 10-16.
48. Smit MJ, Vischer HF, Bakker RA, Jongejan A, Timmerman H, Pardo L etal. (2007). Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. Annu Rev Pharmacol Toxicol 47: 53-87.
49. Stankov B, Cozzi B, Lucini V, Capsoni S, Fauteck J, Fumagalli P (1991). Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding. Neurosa Lett 133: 68-72.
50. Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y et al (2005). The regional and cellular expression profile of the melatonin receptor MTl in the central dopaminergic system. Brain Res Mol Brain Res 136: 45-53. (Pubitemid 40704608)
51. Verdonk E, Johnson K, McGuinness R, Leung G, Chen YW, Tang HR et al. (2006). Cellular dielectric spectroscopy: a label-free comprehensive platform for functional evaluation of endogenous receptors. Assay Drug Dev Technol 4: 609-619. (Pubitemid 46017404)
52. Wan Q, Man HY, Liu F, Braunton J, Niznik HB, Pang SF et al. (1999). Differential modulation of GABAA receptor function by Mella and Mel1b receptors. Nat Neurosci 2: 401-403. (Pubitemid 30491246)
53. Wang LM, Suthana NA, Chaudhury D, Weaver DR, Colwell CS (2005). Melatonin inhibits hippocampal long-term potentiation. Eur J. Neurosci 22: 2231-2237. (Pubitemid 41653536)
54. Weaver DR, Reppert SM (1996). The Mella melatonin receptor gene is expressed in human suprachiasmatic nuclei. Neuroreport 8:109-112.
55. Weaver DR, Liu C, Reppert SM (1996). Nature's knockout: the Mellb receptor is not necessary for reproductive and circadlan responses to melatonin in Siberian hamsters. Mol Endocrinol 10: 1478-1487. (Pubitemid 26423236)
56. Wu YH, Zhou JN, Balesar R, Unmehopa U, Bao A, Jockers R et al (2006). Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MTl with vasopressin, oxytocin, and cortlcotropln-releasing hormone. J Comp Neurol 499: 897-910. (Pubitemid 44892817)
57. Xiao CT, Chu MX, Fu Y, Fang L, Ye SC (2007). Analysis of polymorphism, structure and function of exon 2 of ovine melatonin receptor lb gene: a clue as to why it lacks expression in sheep. J Pineal Res 42: 97-104. (Pubitemid 44924331)